HemaSphere Articles
HemaSphere is an open access journal, powered by EHA, and dedicated to supporting hematology patient care, research, and education worldwide. Browse the selected articles below, featuring the latest publications relating to specific themes highlighted at EHA25.
Acute leukemia
- Atypical Presentation of Erythroid/Megakaryocytic Leukemic Transformation of a Myeloproliferative Neoplasm Associated with Mutation and Loss of TP53
- Patrolling Monocytes Watch Over Relapse
- Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-Threatening Features Within the Early Post-engraftment Phase
- Clonal Hematopoiesis in Hospitalized Elderly Patients With COVID-19
- Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
Red & white cell disorders
- Recommendations for Pregnancy in Rare Inherited Anemias
- Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic
- MEMSID: Results From a Phase 2 Pilot Study on Memantine Treatment for Sickle Cell Disease
- Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial
Coagulation disorders
- A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy
- D-dimer in COVID-19: A Guide with Pitfalls
Basic-Translational Research
- Functional Differences Between EBV- and CMV-Specific CD8+ T cells Demonstrate Heterogeneity of T cell Dysfunction in CLL
- CD56ᵈᶦᵐCD16ᵈᶦᵐ Natural Killer (NK) Cells: The Forgotten Population
- Factor VIII Fc Fusion Protein but not FVIII Drives Human Monocyte-Derived Dendritic Cell Activation via FcγRIIa
- The Pediatric Acute Leukemia Fusion Oncogene ETO2-GLIS2 Increases Self-Renewal and Alters Differentiation in a Human Induced Pluripotent Stem Cells-Derived Model
Chronic Myeloid Neoplasms
Chronic Lymphoid Neoplasms and Lymphoma
- How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic
- Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic
- Hodgkin Lymphoma: Comments on ESMO Clinical Practice Guidelines
Immunology
- SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience
- A Phase 2 Study of Nivolumab Using a Fixed Dose of 40 mg (Nivo40) in Patients With Relapsed/Refractory Hodgkin Lymphoma
- Establishment of a High-risk MDS/AML Cell Line YCU-AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7
- SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma
- Controversies in the Treatment of Peripheral T-cell Lymphoma
- Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma
- Challenging the Erythropoiesis Paradigm in β-Thalassemia
- Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial
Back